Towards Healthcare
Life Sciences BPO Market Reaches USD 293.2 Billion in 2025

Life Sciences BPO Market Gains Momentum Amid AI Integration and Clinical Research Growth

According to market projections, the life sciences BPO sector is expected to grow from USD 258 billion in 2024 to USD 895.54 billion by 2034, reflecting a CAGR of 13.64%. The life sciences BPO market is expanding due to increasing clinical trials as well as growing advancements in medical writing. North America led the market due to the presence of robust companies.

  • Insight Code: 5869
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The life sciences BPO market is projected to reach USD XX billion by 2034, growing at a CAGR of XX% from 2024 to 2034.

North America is currently leading the life sciences BPO market due to the presence of robust companies.

The life sciences BPO market includes four segments such as by service type, by phase, by end user, and by region.

Some key players include IQVIA, Parexel International Corporation, Syneos Health, and Labcorp Drug Development.

Key trends include growth in innovations to deal with security challenges and to enhance clinical research.

Life sciences BPO is outsourcing services such as clinical trial management, regulatory compliance, pharmacovigilance, manufacturing, supply chain, as well as sales & marketing, which are provided to the pharmaceutical, biotechnology, and medical device companies.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.